Clinical Trial Services & Solutions Sourcing Center
According to the Alliance of Regenerative Medicine, there were 1,220 clinical trials ongoing at the end of 2020, with 152 of those trials in Phase 3, supporting the FDA's and EMA's predictions they will approve 10-20 cell and gene therapies each year by 2025.
The development of cell and gene therapy trials is both complex and challenging as well as subject to heavy regulatory scrutiny. As new and emerging biotechs and even established pharma drive their research forward through clinical trials, anticipating challenges can be key to bringing therapies from bench to bedside. Biotechs will be faced with important decisions when it comes to clinical development and selecting the right CRO partner is one of those decisions.
How can we help?
Looking for help with your Cell & Gene Therapy clinical trial? If you're searching for information or a supplier, let Life Science Connect lend you a hand.
inSeption Group
inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.
MRN – Medical Research Network
At MRN we understand the complexities of today's clinical trial environment and the burden this places on patients, clients and sites.
Our services are designed to ease these burdens, from community researchers through to investigator site professional support, accelerating patient recruitment and retention.
We work to maximize the efficiency of clinical trials for drug developers, by improving the patient's experience, no matter where their community is in the world.
Novotech
Founded in 1997, Novotech is a global full-service clinical CRO focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase. Novotech offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with 5,000+ clinical projects. The company has 34 office locations and a team of 3,000+ professionals worldwide.
Have questions about your Cell & Gene therapy clinical trial?
The Life Science Connect team can help. We'll match your needs with the right companies.
Contact us via email for assistance.
OpenClinica
OpenClinica is transforming healthcare through innovative cloud technology that simplifies running clinical trials. Proven in over 10,000 studies worldwide, the OpenClinica platform is trusted by leading biopharmaceutical companies, contract research organizations, academic institutions, and government agencies. OpenClinica is used across a wide spectrum of clinical research, including drug, device, and diagnostic trials, global health studies involving 200,000+ patients, adaptive platform trials, and clinical trials for some of the first gene therapies to be approved for market.
Capabilities
Synthego Corporation
Synthego is a genome engineering company that enables life science research and therapy development with a mission of increased access to engineered therapies for all patients. With unparalleled CRISPR expertise, state-of-the-art GMP capabilities, and a continuum of product offerings, Synthego supports CRISPR-edited cell and gene therapeutic development at every step, from R&D through IND submission to first-in-human trials.
Capabilities
Veristat
Veristat, a global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years' experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years alone.
Capabilities